Pfizer Inc. to Appeal Canadian Federal Court Ruling on Lipitor Patent; Court’s Decision Will Have No Immediate Commercial Impact

NEW YORK--(BUSINESS WIRE)--Pfizer Inc said today it will appeal a Canadian Federal Court decision in favor of generic manufacturer Apotex in its challenge to a Pfizer patent covering Lipitor.